Paul Andrew Willis

USPTO Granted Patents = 16 (Patent Applications = 1)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 120(Granted Patents)

Location History:

Nottingham, GB (2001 - 2004)
West Bridgford, GB (1998 - 2007)
Leicestershire, GB (2011)
Loughborough, GB (2004 - 2012)
Geneva, CH (2017)

Company Filing History:

Astra Zeneca U.k. Limited

patents

1 out of 24

Astra Pharmaceuticals Limited

patents

Years Active: 1998-2017

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE46276 - Triazolo(4,5-D)pyrimidine compounds (2017-01-16),

2. 8143261 - Thiazolo (4,5-D) pyrimidine compounds (2012-03-27),

3. 8012979 - Compounds and their uses 707 (2011-09-06),

4. 7408065 - [object Object] (2008-08-05),

5. 7250419 - Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition (2007-07-31),

6. 7132457 - Adamantane derivatives (2006-11-07),

7. 6974868 - Compounds (2005-12-13),

8. 6958344 - Pyrimidine compounds and their use as modulators of chemokine receptor activity (2005-10-25),

9. 6881754 - Adamantane derivatives (2005-04-19),

10. 6806273 - Compounds (2004-10-19),

11. 6790850 - Thiazolo(4,5-d)pyrimidine compounds (2004-09-14),

12. 6525060 - Triazolo(4,5-d)pyrimidine compounds (2003-02-25),

13. 6369064 - Triazolo(4,5-d)pyrimidine compounds (2002-04-09),

14. 6297232 - Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments (2001-10-02),

15. 6251910 - 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists (2001-06-26),

Title: The Innovative Journey of Paul Andrew Willis

Introduction:

Paul Andrew Willis, a visionary inventor based in Loughborough, GB, has made significant contributions to the field of pharmaceuticals with a total of 16 patents under his name.

Latest Patents:

Among his latest patents are groundbreaking inventions in the realm of pharmaceuticals, including Triazolo(4,5-D)pyrimidine compounds and Thiazolo(4,5-D) pyrimidine compounds. These patents showcase his expertise in developing novel medicaments and compositions for therapeutic use.

Career Highlights:

Paul Andrew Willis has lent his inventive prowess to renowned companies such as AstraZeneca AB and AstraZeneca U.K. Limited, where he played a pivotal role in driving innovation and advancing pharmaceutical research. His relentless pursuit of excellence has led to the creation of groundbreaking solutions that have the potential to revolutionize the healthcare industry.

Collaborations:

Throughout his career, Paul Andrew Willis has collaborated with esteemed professionals in the field, including Anthony Howard Ingall and Brian Springthorpe. These partnerships have fostered a culture of innovation, enabling the exchange of ideas and expertise to fuel groundbreaking discoveries.

Conclusion:

In conclusion, Paul Andrew Willis stands as a trailblazing inventor whose contributions to the field of pharmaceuticals have been nothing short of revolutionary. His inventive spirit, coupled with his dedication to pushing the boundaries of scientific exploration, exemplifies the true essence of innovation and discovery in the modern age.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.